TREM2 and coronary atherosclerosis: If this finding is further corroborated by larger studies, soluble TREM2 may stand as a novel biomarker of prognosis in patients with coronary atherosclerosis and pave the way to an improved understanding of the mechanisms governing plaque destabilization.